Microgrids help to achieve power balance and energy allocation optimality for the defined load networks. One of the major challenges associated with microgrids is the design and implementation of a suitable communication-control architecture that can coordinate actions with system operating conditions. In this paper, the focus is to enhance the intelligence of microgrid networks using a multi-agent system while validation is carried out using network performance metrics i.e., delay, throughput, jitter, and queuing. Network performance is analyzed for the small, medium and large scale microgrid using Institute of Electrical and Electronics Engineers (IEEE) test systems. In this paper, multi-agent-based Bellman routing (MABR) is proposed where the Bellman-Ford algorithm serves the system operating conditions to command the actions of multiple agents installed over the overlay microgrid network. The proposed agent-based routing focuses on calculating the shortest path to a given destination to improve network quality and communication reliability. The algorithm is defined for the distributed nature of the microgrid for an ideal communication network and for two cases of fault injected to the network. From this model, up to 35%-43.3% improvement was achieved in the network delay performance based on the Constant Bit Rate (CBR) traffic model for microgrids.
Taurine is a sulfur-containing, semi-essential amino acid that occurs naturally in the body. It alternates between inflammation and oxidative stress-mediated injury in various disease models. As part of its limiting functions, taurine also modulates endoplasmic reticulum stress, Ca2+ homeostasis, and neuronal activity at the molecular level. Taurine effectively protects against a number of neurological disorders, including stroke, epilepsy, cerebral ischemia, memory dysfunction, and spinal cord injury. Although various therapies are available, effective management of these disorders remains a global challenge. Approximately 30 million people are affected worldwide. The design of taurine formation could lead to potential drugs/supplements for the health maintenance and treatment of central nervous system disorders. The general neuroprotective effects of taurine and the various possible underlying mechanisms are discussed in this review. This article is a good resource for understanding the general effects of taurine on various diseases. Given the strong evidence for the neuropharmacological efficacy of taurine in various experimental paradigms, it is concluded that this molecule should be considered and further investigated as a potential candidate for neurotherapeutics, with emphasis on mechanism and clinical studies to determine efficacy.